EVAX

EVAXION AS

EVAX·29970R303·US·ADR·Healthcare - Biotechnology-13D/G

EVAX (EVAXION AS) is held by 9 institutional investors as of Q2 2026. Largest holders: Rathbones Group PLC ($141,741), CITADEL ADVISORS LLC ($113,410), RENAISSANCE TECHNOLOGIES LLC ($104,780). Net institutional sentiment: Mixed.

9
Holders
(1 Elite)
$577,685
Total Value
63% (8)
Consensus
5 buying - 3 selling
13F: Insider & Congress: Updated regularly
EVAX

Smart Money Verdict

View all
Loading verdict
Held by 9 funds
1 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders none · Activists May 15, 2025 · Congress none

ActivistARArmistice Capital, LLC5.0%May 15, 2025

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
45,723(-50.0%)$141,7410.0%+3.85%
0
Increased
36,584(+105.8%)$113,4100.0%+4.19%
24
Decreased
33,800(-13.8%)$104,7800.0%+3.85%
0
Increased
21,849(+0.9%)$67,7230.0%-25.51%
21
New
20,581$63,8010.0%+4.52%
32
Decreased
12,899(-41.5%)$39,9870.0%+3.85%
0
Unchanged
8,000$24,8000.0%-32.22%
0
New
6,275$19,4530.0%+4.52%
29
New
642$1,9900.0%+4.52%
17
EVAXEVAXEVAXION AS

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used